India is moving from generic drugs to new molecules

India is moving from generics and affordable medicines instead it is now focussing innovations to evolve new drug molecules. A case in point is Glenmark an Indian company which is moving faster than its competitors in the field of innovative pharmaceuticals with seven of its new molecules in various stages of development.